|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
价值评估 |
盈利(现时/预测)
-0.91/0.55
|
企业价值
285.87M
|
资产负债 |
每股账面净值
1.28
|
现金流量 |
现金流量率
--
|
损益表 |
收益
239.23K
|
每股收益
0.00
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
报价延迟最少15分钟:2024/04/29 04:48 EDT
同行比较之报价最少15分钟延迟
业务概览
|
|||
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. |